Driving Efficiencies in Clinical Trials Catalyst Flex at SCOPE 2025 This year, I attended the SCOPE 2025 conference with key Read Now
Driving Innovation in Radiopharmaceutical Therapies Oncology clinical research is complex, demanding, and continually evolving. Bringing effective radiopharmaceutical therapies from proof-of-concept Read Now
A View of the Joint Clinical Assessment (JCA) Process An out-of-the-box solution to navigate regulation effectively The Joint Clinical Assessment (JCA) is a pivotal Read Now
The Evolving Landscape of Oncology Drug Development Increasing incidence rates and the rise of novel therapies Oncology is the largest therapeutic area Read Now
Partnering with Functional Service Providers How culture drives success Consultants across industries suggest that a better corporate culture — one Read Now
Developing Next-generation Therapies for Breast Cancer Patients Breast cancer is the second most common malignancy worldwide and the number one cancer in Read Now
Helping to Develop Cell Therapies Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now
Highlights from the San Antonio Breast Cancer Symposium Celebrating new therapies, addressing challenges, and committing to patient advocacy I was thrilled to attend Read Now
Catalyst Welcomes New Vice President Sarah St. John, PhD, joins business development team Catalyst Clinical Research is thrilled to welcome Read Now